Jove
Visualize
Contact Us

Briganti Alberto

13PUBLICATIONS
125CO-AUTHORS
Molecular targetsMortalityPredictive and prognostic markersMajor global burdens of diseaseRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

Sort by Publication Date:
|Mar 05, 2026
Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine Progression.

Arianna Brevi, Marco Lorenzoni, Sara Caputo

|Dec 15, 2025
Socioeconomic Disparities in Prostate Cancer Treatment: The Impact of Area Deprivation Index on Initial Treatment Type for Localized Prostate Cancer in a North American Statewide Cohort.

Antonio Perri, Anna Tylecki, Silvia Viganò

|Jun 20, 2025
Impact of Molecular Androgen and Estrogen Response Scores on Outcomes Following Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer.

Valentina Tateo, Joep J de Jong, Antonio Cigliola

|May 30, 2025
Socioeconomic disparities and bladder cancer stage at diagnosis: a statewide cohort analysis.

Alessio Finocchiaro, Anna Tylecki, Silvia Viganò

|Jan 23, 2025
Immunotherapy-based neoadjuvant treatment and complication rates after radical cystectomy.

Reuben Ben-David, Francesco Pellegrino, Reza Mehrazin

|Nov 22, 2024
Association of race and area of deprivation index with prostate cancer incidence and lethality: results from a contemporary North American cohort.

Marco Finati, Alex Stephens, Giuseppe Ottone Cirulli

Pageof 3

Frequent Collaborators

4 joint publications

Francesco Montorsi

3 joint publications

Firas Abdollah

3 joint publications

Marco Moschini

3 joint publications

Salonia Andrea

3 joint publications

Maurizio Colecchia

2 joint publications

Andrea Necchi

2 joint publications

Reha-Baris Incesu

2 joint publications

Martina Sollini

2 joint publications

Fabrizia Gelardi

2 joint publications

Gaia Ninatti

Frequent Collaborators

4 joint publications

Francesco Montorsi

3 joint publications

Firas Abdollah

3 joint publications

Marco Moschini

3 joint publications

Salonia Andrea

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Top Related Videos

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture
10:38

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture

Published on : Nov 22, 2019

9.6K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on : Mar 06, 2018

13.7K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

5.1K
See more related videos

Top Related Videos

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture
10:38

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture

Published on : Nov 22, 2019

9.6K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on : Mar 06, 2018

13.7K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

5.1K
See more related videos